Squamous Cell Carcinoma of Head and Neck - cisplatin + docetaxel + 5-fluorouracil - No biomarker

Association details:

Biomarker:	No biomarker
Cancer:	Squamous Cell Carcinoma of Head and Neck
Drug:	cisplatin (DNA synthesis inhibitor) + docetaxel (Tubulin polymerization promoter, Microtubule stabilizer) + 5-fluorouracil (Thymidylate synthase inhibitor)
Direction:	Sensitive

Evidence:

Evidence Level:

Sensitive: A1 - Approval

Source:

FDA

Published date:

01/13/2021

Excerpt:

Docetaxel Injection is a microtubule inhibitor indicated for...Squamous Cell Carcinoma of the Head and Neck (SCCHN): with cisplatin and fluorouracil for induction treatment of locally advanced SCCHN